Canaccord Genuity maintains a 'Hold' on AngioDynamics (Nasdaq: ANGO), lowers PT from $17 to $15.

Canaccord analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE